I submitted an article ("Cytokine Release Syndrome after Tisagenlecleucel Infusion in Pediatric Patients with Refractory/Relapsed B-Lineage Acute Lymphoblastic Leukemia: Is there a Role for Diclofenac?to AustinPublishing Group (a predator journal?). They have published my articleon line without DOI although I have specified that I did not want to publish it anymore (I wrote to withdrawn several times) because I would not have paid the fees. After that I resubmitted the article to Tumori Journal and It was accepted for publication. Do you think that problems can arise? What do you suggest?

Tumori journal suggest to ask you an opinion on this matter.

Thank-you in advance

Sara Napolitano

More Sara Napolitano's questions See All
Similar questions and discussions